Orchestra BioMed Holdings, Inc. (OBIO): Cash & Equivalents

Annual figures by period end, from SEC filings.

$34.69M
As of 2025-12-31
$20.47M
As of 2026-06-30
+20.6%
3-year compound annual growth
+76.5%
5-year compound annual growth
2020-12-31: $2.03M2021-12-31: $1.75M2022-12-31: $19.78M2023-12-31: $30.56M2024-12-31: $22.26M2025-12-31: $34.69M$34.69M
2020-12-31 Cash & Equivalents (USD) 2025-12-31
Period endedCash & EquivalentsChange YoYSource filing
2025-12-31$34.69M+55.8%2026-03-12, Balance as of period end
2024-12-31$22.26M-27.2%2026-03-12, Balance as of period end
2023-12-31$30.56M+54.5%2025-03-31, Balance as of period end
2022-12-31$19.78Mn/m2024-03-27, Balance as of period end
2021-12-31$1.75M-13.4%2023-01-25, Balance as of period end
2020-12-31$2.03Mn/a2022-03-31, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCash & EquivalentsChange YoY
Orchestra BioMed Holdings, Inc. (OBIO)2025-12-31$34.69M+55.8%
ClearPoint Neuro, Inc. (CLPT)2025-12-31$45.92M+128.4%
Cytosorbents Corp (CTSO)2025-12-31$6.25M+90.5%
Retractable Technologies Inc (RVP)2025-12-31$2.59M-38.9%
Utah Medical Products Inc (UTMD)2025-12-31$85.76M+3.4%
Interpace Biosciences, Inc. (IDXG)2025-12-31$2.50M+71.5%
Sensus Healthcare, Inc. (SRTS)2025-12-31$22.08M+0.1%
KORU Medical Systems, Inc. (KRMD)2025-12-31$8.87M-7.4%
SS Innovations International, Inc. (SSII)2025-12-31$3.21M+587.3%

Compare OBIO, CLPT, CTSO, RVP side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗